Clinical Trials Logo

Healthy Subjects clinical trials

View clinical trials related to Healthy Subjects.

Filter by:

NCT ID: NCT05311878 Completed - Healthy Subjects Clinical Trials

Non-invasive BCI for Cognitive Enhancement

Start date: January 1, 2021
Phase: N/A
Study type: Interventional

People's perceptual skills can significantly affect their abilities to make optimal decisions, judgments, and actions in real-world dynamic environments. Perceptual learning refers to training and experiences to induce improvements in the ability to make sense of what people see, hear, feel, taste or smell based on ambiguous sensory information. In this study, investigators hypothesise that there exist neural signatures that robustly encode the conscious visual perception of rotations of a cursor and the magnitudes of these rotations in a novel, rotation-based perceptual learning task. Investigators also hypothesise that online, instantaneous EEG-based feedback on subjects' visual perceptions of rotations with an EEG-based Brain Computer Interface (BCI) can foster perceptual learning much more effectively than behaviour perceptual training, especially in very small rotation magnitudes that represent extremely difficult perceptual tasks.

NCT ID: NCT05309915 Completed - Healthy Subjects Clinical Trials

A Study of STP707 Administered by IV in Healthy Subjects

Start date: February 28, 2022
Phase: Phase 1
Study type: Interventional

Single center study, randomized, to evaluate safety, tolerability, PK of single ascending dose of STP707 when administered by IV infusion in healthy subjects.

NCT ID: NCT05298046 Active, not recruiting - Healthy Subjects Clinical Trials

Study of TAVO101 in Healthy Volunteers

Start date: May 11, 2022
Phase: Phase 1
Study type: Interventional

This is a Phase 1, single ascending dose study designed to investigate TAVO101, administered as an IV infusion in healthy subjects. This study is designed to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of TAVO101.

NCT ID: NCT05297968 Completed - Healthy Subjects Clinical Trials

Study on the Human Bioequivalence of Oseltamivir Phosphate For Oral Suspension

Start date: May 13, 2021
Phase: Phase 1
Study type: Interventional

an open label,balanced,randomized,two-treatment,two-period,two-sequence,single dose,crossover,oral bioequivalence Study of oseltamivir phosphate for oral suspension in healthy ,adult,human subjects under fasted/fed conditions.

NCT ID: NCT05293171 Completed - Healthy Subjects Clinical Trials

Study to Investigate the Effect of BL-8040 (Motixafortide) on the QTc Interval in Healthy Subjects

Start date: June 11, 2021
Phase: Phase 1
Study type: Interventional

The study will assess the corrected QT (QTc) effects (electrocardiogram [ECG]) of BL-8040 1.25 mg/kg (therapeutic dose) and 2 mg/kg (supratherapeutic dose) following a single subcutaneous (SC) injection relative to placebo in approximately 40 healthy subjects.

NCT ID: NCT05268406 Recruiting - Healthy Subjects Clinical Trials

Evaluation of C-Scan in Identifying Subjects With Elevated Risk of Polyps in the Colon

Start date: July 29, 2020
Phase: N/A
Study type: Interventional

The purpose of the first part of the study (subgroup R&D) is to demonstrate the safety and performance of the C-Scan system and to collect data in order to improve the analysis process. The purpose of the second part of the study (subgroup pre-pivotal) is to determine the ability of the C-Scan System to identify elevated risk subjects

NCT ID: NCT05265338 Completed - Healthy Subjects Clinical Trials

A Food Effect Study of KC1036 in Healthy Subjects

Start date: March 10, 2022
Phase: N/A
Study type: Interventional

The primary objective of the study was to assess the effect of High Fat Diet on the pharmacokinetics of KC1036 in Chinese adult healthy subjects.

NCT ID: NCT05259189 Completed - Healthy Subjects Clinical Trials

A Study of NBL-012 in Healthy Chinese Subjects

Start date: July 1, 2021
Phase: Phase 1
Study type: Interventional

This is a phase 1, randomized, double-blind, placebo-controlled, sequential cohort study to evaluate the safety, tolerability and pharmacokinetics (PK) of NBL-012 as single ascending doses (SAD) administered subcutaneously to healthy Chinese subjects.

NCT ID: NCT05241535 Completed - Healthy Subjects Clinical Trials

Study to Evaluate the Effect of a Single Oral Dose of MT-7117 on the QT/QTc Interval in Healthy Subjects

Start date: January 12, 2022
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the effect of a single oral dose of MT-7117 on the QT/QTc interval in healthy subjects.

NCT ID: NCT05236998 Completed - Healthy Subjects Clinical Trials

A Pharmacokinetic Study of SID1903 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers

Start date: November 3, 2021
Phase: Phase 1
Study type: Interventional

This study is to compare and evaluate the safety and pharmacokinetic characteristics (PK) after administration of SID1903 and SID1903-R1/SID1903-R2 in healthy adult volunteers.